Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Aspen Pharmacare (APNHY) had Revenue of $2.39B for the most recently reported fiscal year, ending 2024-06-30.

Quarterly Annual

Figures for fiscal year ending 2024-06-30

Income Statement Financials
Revenue	$2.39B
Net Income	$235.61M
Cost of Goods Sold	$1.35B
Gross Profit	$1.04B
Operating Expenses	$2.02B
Operating Income	$374.39M
Non-Operating Income/Expense	$-68.69M
Pre-Tax Income	$305.70M
Normalized Pre-Tax Income	$305.70M
Income after Taxes	$235.61M
Income from Continuous Operations	$235.61M
Consolidated Net Income/Loss	$235.61M
Normalized Income after Taxes	$235.61M
EBIT	$374.39M
EBITDA	$479.95M
Weighted-Average Shares Outstanding (Basic)	444.20M
Weighted-Average Shares Outstanding (Diluted)	444.20M
Earnings per Share (EPS) (Basic)	$0.53
Earnings per Share (EPS) (Diluted)	$0.53
Balance Sheet Financials
Current Assets	$2.36B
Property, Plant, and Equipment	$1.07B
Long-Term Assets	$5.09B
Total Assets	$7.44B
Current Liabilities	$1.30B
Long-Term Debt	$1.35B
Long-Term Liabilities	$1.60B
Total Liabilities	$2.90B
Common Equity	$4.54B
Tangible Shareholders Equity	$698.01M
Shareholders Equity	$4.54B
Common Shares Outstanding	444.23M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$333.04M
Cash Flow from Investing Activities	$-506.54M
Cash Flow from Financial Activities	$193.83M
Beginning Cash	$400.88M
End Cash	$386.27M
Increase/Decrease in Cash	$-14.61M
Stock-Based Compensation	$6.26M
Common Stock Dividends Paid	$-81.59M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.81
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.23
Debt to Equity Ratio	0.43
Gross Margin	43.52%
Operating Margin	15.65%
EBIT Margin	15.65%
EBITDA Margin	20.07%
Pre-Tax Profit Margin	12.78%
Profit Margin	9.85%
Free Cash Flow	$167.46M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.32
Inventory Turnover	1.40
Receiveable Turnover	3.25
Days Sales in Receivables	112.24
Return on Equity	5.19%
Return on Tangible Equity	33.75%
Return on Assets	3.16%
Return on Investments	4.00%
Book Value Per Share	$10.22
Free Cash Flow per Share	$0.38
Operating Cash Flow per Share	$0.75

Data from Zacks Investment Research, Inc.